{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:34:08Z","timestamp":1785281648540,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.medcli.2016.10.019","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T10:00:40Z","timestamp":1480932040000},"page":"271-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Diagn\u00f3stico y tratamiento de la gota"],"prefix":"10.1016","volume":"148","author":[{"given":"Francisca","family":"Sivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Quilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2016.10.019_bib0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2013-203325","article-title":"Multinational evidence-based recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative","volume":"73","author":"Sivera","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2016.10.019_bib0160","doi-asserted-by":"crossref","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2016; doi: 10.1136\/annrheumdis-2016-209707. Epub ahead of print [accessed 16 Nov 2016]. Available from: http:\/\/ard.bmj.com\/content\/early\/2016\/07\/25\/annrheumdis-2016-209707.long","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"10.1016\/j.medcli.2016.10.019_bib0165","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.medcli.2016.10.019_bib0170","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","article-title":"Synovial fluid analysis for diagnosis of intercritical gout","volume":"131","author":"Pascual","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medcli.2016.10.019_bib0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2011.154997","article-title":"Diagnosis of gout in patients with asymptomatic hyperuricaemia: A pilot ultrasound study","volume":"71","author":"De Miguel","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2016.10.019_bib0180","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/annrheumdis-2014-206397","article-title":"Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: A dual energy CT study","volume":"74","author":"Dalbeth","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2016.10.019_bib0185","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/art.39581","article-title":"Silent monosodium urate crystal deposits are associated with severe coronary calcification in asymptomatic hyperuricemia: An exploratory study","volume":"68","author":"Andr\u00e9s","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.medcli.2016.10.019_bib0190","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/rheumatology\/kev339","article-title":"In vivo detection of monosodium urate crystal deposits by Raman spectroscopy--A pilot study","volume":"55","author":"Abhishek","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.medcli.2016.10.019_bib0195","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/RHU.0b013e3182314d40","article-title":"An audit of the variability of diagnosis and management of gout in the rheumatology setting: The gout evaluation and management study","volume":"17","author":"Perez-Ruiz","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.medcli.2016.10.019_bib0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/RHU.0b013e3181945b79","article-title":"Clinical diagnostic criteria for gout: Comparison with the gold standard of synovial fluid crystal analysis","volume":"15","author":"Malik","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.medcli.2016.10.019_bib0205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ard.2008.104406","article-title":"EULAR\/EFORT recommendations for the diagnosis and initial management of patients with acute or recent onset swelling of the knee","volume":"69","author":"Landewe","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2016.10.019_bib0210","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"Gout classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2016.10.019_bib0215","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/rheumatology\/ket293","article-title":"Gout as a risk factor for myocardial infarction and stroke in England: Evidence from record linkage studies","volume":"52","author":"Seminog","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2016.10.019_bib0220","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2016.10.019_bib0225","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/ard.2006.060368","article-title":"Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout","volume":"66","author":"Pascual","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2016.10.019_bib0230","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.medcli.2016.10.019_bib0235","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2016.10.019_bib0240","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase iii, randomized, double-blind, parallel-group trial","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2016.10.019_bib0245","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/ard.2008.091462","article-title":"A randomised-controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600mg\/day versus benzbromarone 100-200mg\/day in patients with gout","volume":"68","author":"Reinders","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2016.10.019_bib0250","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/art.34488","article-title":"Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of alopurinol","volume":"64","author":"Stamp","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2016.10.019_bib0255","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3899\/jrheum.110092","article-title":"Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions","volume":"38","author":"Chohan","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2016.10.019_bib0260","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.57.9.545","article-title":"Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout","volume":"57","author":"Perez-Ruiz","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2016.10.019_bib0265","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00002018-200831080-00002","article-title":"A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?","volume":"31","author":"Lee","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.medcli.2016.10.019_bib0270","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/annrheumdis-2015-207919","article-title":"Lesinurad in combination with allopurinol: Results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol","volume":"75","author":"Perez-Ruiz","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2016.10.019_bib0275","first-page":"2093","article-title":"Rasburicase for tophaceous gout not treatable with allopurinol: An exploratory study","volume":"34","author":"Richette","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2016.10.019_bib0280","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0140-6736(08)60799-0","article-title":"Use of oral prednisolone or naproxen for the treatment of gout arthritis: A double-blind, randomised equivalence trial","volume":"371","author":"Janssens","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2016.10.019_bib0285","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2016.10.019_bib0290","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","article-title":"Canakinumab for acute gouty arthritis in patients with limited treatment options: Results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions","volume":"71","author":"Schlesinger","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2016.10.019_bib0295","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","article-title":"Alcohol intake and risk of incident gout in men: A prospective study","volume":"363","author":"Choi","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2016.10.019_bib0300","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/annrheumdis-2011-200156","article-title":"Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: A proof-of-concept randomised controlled trial","volume":"71","author":"Dalbeth","year":"2012","journal-title":"Ann Rheum Dis"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775316305280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775316305280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T01:57:21Z","timestamp":1536199041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775316305280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0025775316305280"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2016.10.019","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagn\u00f3stico y tratamiento de la gota","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2016.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}